These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 29846953)
21. Expression of Endothelin-1, Endothelin Receptor-A, and Endothelin Receptor-B in facial melasma compared to adjacent skin. da Silva CN; Miot HA; Grassi TF; Dias-Melício LA; Santos L; Espósito ACC Clin Cosmet Investig Dermatol; 2023; 16():2847-2853. PubMed ID: 37850109 [TBL] [Abstract][Full Text] [Related]
22. In vivo multiphoton microscopy of melasma. Lentsch G; Balu M; Williams J; Lee S; Harris RM; König K; Ganesan A; Tromberg BJ; Nair N; Santhanam U; Misra M Pigment Cell Melanoma Res; 2019 May; 32(3):403-411. PubMed ID: 30506627 [TBL] [Abstract][Full Text] [Related]
23. Ultrastructural characterization of damage in the basement membrane of facial melasma. Espósito ACC; Brianezi G; de Souza NP; Santos DC; Miot LDB; Miot HA Arch Dermatol Res; 2020 Apr; 312(3):223-227. PubMed ID: 31531731 [TBL] [Abstract][Full Text] [Related]
24. Depigmenting topical therapy based on a synergistic combination of compounds targeting the key pathways involved in melasma pathophysiology. Alfredo MG; Maribel PM; Eloy PR; Susana GE; Luis LGS; Carmen GM Exp Dermatol; 2023 May; 32(5):611-619. PubMed ID: 36682042 [TBL] [Abstract][Full Text] [Related]
25. Application of computerized image analysis in pigmentary skin diseases. Lee ES; Kim JH; Im S; Lee KB; Sohn S; Kang WH Int J Dermatol; 2001 Jan; 40(1):45-9. PubMed ID: 11277953 [TBL] [Abstract][Full Text] [Related]
26. Heterogeneous Pathology of Melasma and Its Clinical Implications. Kwon SH; Hwang YJ; Lee SK; Park KC Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27240341 [TBL] [Abstract][Full Text] [Related]
27. Histochemical and immunohistochemical study in melasma: evidence of damage in the basal membrane. Torres-Álvarez B; Mesa-Garza IG; Castanedo-Cázares JP; Fuentes-Ahumada C; Oros-Ovalle C; Navarrete-Solis J; Moncada B Am J Dermatopathol; 2011 May; 33(3):291-5. PubMed ID: 21317614 [TBL] [Abstract][Full Text] [Related]
28. Efficacy and possible mechanisms of topical tranexamic acid in melasma. Kim SJ; Park JY; Shibata T; Fujiwara R; Kang HY Clin Exp Dermatol; 2016 Jul; 41(5):480-5. PubMed ID: 27135282 [TBL] [Abstract][Full Text] [Related]
29. Exploratory Study of Epidermis, Basement Membrane Zone, Upper Dermis Alterations and Wnt Pathway Activation in Melasma Compared to Adjacent and Retroauricular Skin. Espósito ACC; Brianezi G; de Souza NP; Miot LDB; Miot HA Ann Dermatol; 2020 Apr; 32(2):101-108. PubMed ID: 33911720 [TBL] [Abstract][Full Text] [Related]
30. Tape stripping and lipidomics reveal skin surface lipid abnormity in female melasma. Xu J; Lu H; Luo H; Hu Y; Chen Y; Xie B; Du X; Hua Y; Song X Pigment Cell Melanoma Res; 2021 Nov; 34(6):1105-1111. PubMed ID: 33974351 [TBL] [Abstract][Full Text] [Related]
31. In vivo reflectance confocal microscopy detects pigmentary changes in melasma at a cellular level resolution. Kang HY; Bahadoran P; Suzuki I; Zugaj D; Khemis A; Passeron T; Andres P; Ortonne JP Exp Dermatol; 2010 Aug; 19(8):e228-33. PubMed ID: 20497220 [TBL] [Abstract][Full Text] [Related]
32. Understanding Mechanisms and Key Factors Influencing Melanogenesis for the Management of Melasma: An Updated Review. Singh NK; Verma AK; Gupta JK Curr Pharm Biotechnol; 2024 May; ():. PubMed ID: 38738729 [TBL] [Abstract][Full Text] [Related]
33. Q-switched Nd: YAG laser alone or with modified Jessner chemical peeling for treatment of mixed melasma in dark skin types: A comparative clinical, histopathological, and immunohistochemical study. Saleh F; Moftah NH; Abdel-Azim E; Gharieb MG J Cosmet Dermatol; 2018 Jun; 17(3):319-327. PubMed ID: 29057567 [TBL] [Abstract][Full Text] [Related]
34. Wnt inhibitory factor (WIF)-1 promotes melanogenesis in normal human melanocytes. Park TJ; Kim M; Kim H; Park SY; Park KC; Ortonne JP; Kang HY Pigment Cell Melanoma Res; 2014 Jan; 27(1):72-81. PubMed ID: 24131586 [TBL] [Abstract][Full Text] [Related]
35. Estrogen receptor expression in melasma: results from facial skin of affected patients. Lieberman R; Moy L J Drugs Dermatol; 2008 May; 7(5):463-5. PubMed ID: 18505139 [TBL] [Abstract][Full Text] [Related]
36. Recent development of signaling pathways inhibitors of melanogenesis. Pillaiyar T; Manickam M; Jung SH Cell Signal; 2017 Dec; 40():99-115. PubMed ID: 28911859 [TBL] [Abstract][Full Text] [Related]
37. H19 RNA downregulation stimulated melanogenesis in melasma. Kim NH; Lee CH; Lee AY Pigment Cell Melanoma Res; 2010 Feb; 23(1):84-92. PubMed ID: 19968822 [TBL] [Abstract][Full Text] [Related]
38. Extra-facial melasma: clinical, histopathological, and immunohistochemical case-control study. Ritter CG; Fiss DV; Borges da Costa JA; de Carvalho RR; Bauermann G; Cestari TF J Eur Acad Dermatol Venereol; 2013 Sep; 27(9):1088-94. PubMed ID: 22827850 [TBL] [Abstract][Full Text] [Related]
39. The dermal stem cell factor and c-kit are overexpressed in melasma. Kang HY; Hwang JS; Lee JY; Ahn JH; Kim JY; Lee ES; Kang WH Br J Dermatol; 2006 Jun; 154(6):1094-9. PubMed ID: 16704639 [TBL] [Abstract][Full Text] [Related]
40. Cadherin 11 Involved in Basement Membrane Damage and Dermal Changes in Melasma. Kim NH; Choi SH; Lee TR; Lee CH; Lee AY Acta Derm Venereol; 2016 Jun; 96(5):635-40. PubMed ID: 26671310 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]